Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1045-1050

  Bruinsma, Nienke ^a   Kristinsson, Karl G ^b,f   Bronzwaer, Stef ^c   Schrijnemakers, Paul ^a   Degener, John ^d   Tiemersma, Edine ^a,f   Hryniewicz, Waleria ^e,f   Monen, Jos ^a   Grundmann, Hajo ^a   Mittermayer, H ^f   Koller, W ^f   Goossens, H ^f   Hendrickx, E ^f   Markova, B ^f   Kalenic, S ^f   Tambic Andrasevic, A ^f   Urbaskova, P ^f   Monnet, D ^f   Naaber, P ^f   Lyytikainen O ^f   Nissinen, A ^f   Aubry Damon, H ^f   Courvalin, P ^f   Buchholz, U ^f   Witte, W ^f   Legakis, N ^f   Vatopoulos, G ^f   Fuzi M ^f   O'Flanagan, D ^f   Murphy, O ^f   Raz, R ^f   Edelstein, H ^f   Cornaglia, G ^f   D'Ancona, P ^f   Hemmer, R ^f   Borg, M ^f   de Neeling, A ^f   Hoiby, A ^f   Bjorlow E ^f   Canica M ^f   Codita, I ^f   Gubina, M ^f   Kolman, J ^f   Langsadl, L ^f   Baquero, F ^f   Campos, J ^f   Liljequist, B ^f   Johnson, A ^f   Wale, M ^f   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c EUROPEAN COMMISSION   (Belgium)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e NATIONAL MEDICINES INSTITUTE   (Poland)

^f NONE

Author keywords

Antimacrobial use; Antimicrobial resistance; Public health

Indexed keywords

BETA LACTAM ANTIBIOTIC; ERYTHROMYCIN; MACROLIDE; OXACILLIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BELGIUM; CONTROLLED STUDY; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG USE; EUROPE; FINLAND; FORECASTING; FREQUENCY ANALYSIS; GEOGRAPHIC DISTRIBUTION; GERMANY; INFECTION CONTROL; IRELAND; ITALY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PREDICTION; STREPTOCOCCUS PNEUMONIAE; SWEDEN; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; EUROPE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 19944431669     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh458     Document Type: Article

References (26)

1. Moellering, R. C. (2002). The continuing challenge of lower respiratory tract infections. Clinical Infectious Diseases 34 S1-S3.
2. Whitney, C. G., Farley, M. M., Hadler, J. et al. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New England Journal of Medicine 343, 1917-24.
3. Thamdrup Rosdahl, V. & Borge Pederson, K., Eds (1998). The Microbial Threat. Recommendations of European Union Conference on The Microbial Threat, 1998, September 9-10, Copenhagen. Ministry of Health and Ministry of Food, Agriculture and Fisheries, Denmark.
4. Bronzwaer, S. L. A. M. & Sprenger, M. J. W. (1998). A surveillance system for Europe. British Medical Journal 317, 615.
5. Bronzwaer, S. L. A. M., Goettsch, W., Olsson-Liljequist, B. et al. (1999). European Antimicrobial Resistance Surveillance System (EARSS): objectives and organisation. Eurosurveillance 4 41.
6. Swenson, J. M., Hill, B. C. & Thornsberry, C. (1986). Screening pneumococci for penicillin resistance. Journal of Clinical Microbiology 24, 749-52.
7. Goettsch, W., Bronzwaer, S. L. A. M., de Neeling, A. J. et al. (2000). Standardization and quality assurance for antimicrobial resistance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS). Clinical Microbiology and Infection 6, 59-63.
8. Bronzwaer, S., Buchholz, U., Courvalin, P. et al. (2002). Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS). Journal of Antimicrobial Chemotherapy 50, 953-64.
9. McCormick, A. W., Whitney, C. G., Farley, M. M. et al. (2003). Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nature Medicine 9, 424-30.
10. Lipsitch, M. (2001). The rise and fall of antimicrobial resistance. Trends in Microbiology 9, 438-44.
11. Felmingham, D., Reinert, R. R., Hirakata, Y. et al. (2002). Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. Journal of Antimicrobial Chemotherapy 50, Suppl. S1, 25-S37.
12. Jacobs, M. R., Felmingham, D., Appelbaum, P. C. et al. (2003). The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Journal of Antimicrobial Chemotherapy 52, 229-46.
13. Pihlajamaki, M., Kaijalainen, T., Huovinen, P. et al. (2002). Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000. Journal of Antimicrobial Chemotherapy 49, 785-92.
14. Harbarth, S., Albrich, W., Goldmann, D. A. et al. (2001). Control of multiply resistant cocci: do international comparisons help? Lancet Infectious Diseases 1, 251-61.
15. Gonzales, R., Malone, D. C., Maselli, J. H. & Sande, M. A. (2001). Excessive antibiotic use for acute respiratory infections in the United States. Clinical Infectious Diseases 33, 757-62.
16. Schrag, S. J., Pena, C., Fernandez, J. et al. (2001). Effect of short-course high-dose amoxicillin therapy on resistant pneumococcal carriage. Journal of the American Medical Association 286, 49-56.
17. Jacobs, M. R. & Johnson, C. E. (2003). Macrolide resistance: an increasing concern for treatment failure in children. Paediatric Infectious Diseases Journal 22, S131-8.
18. Hyde, T. B., Gay, K., Stephens, D. S. et al. (2001). Macrolide resistance among invasive Streptococcus pneumoniae isolates. Journal of the American Medical Association 286, 1857-62.
19. Jacobs, M. R. (2002). In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure. Clinical Infectious Diseases 35, 565-9.
20. Lonks, J. R., Garau, J., Gomez, L. et al. (2002). Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clinical Infectious Diseases 35, 556-64.
21. Waterer, G. W., Wunderink, R. G. & Jones, C. B. (2002). Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy. Chest 118, 1839-40.
22. Garcia-Rey, C., Aguilar, L., Baquero, F. et al. (2002). Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. Journal of Clinical Microbiology 40, 159-64.
23. Baquero, F., Baquero-Artigao, G., Canton, R. et al. (2002). Antibiotic consumption and resistance selection in Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 50 Suppl. S2, 27-S37.
24. Mbelle, N., Huebner, R. E., Wasas, A. D. et al. (1999). Immunogenicity and impact on nasopharyngeal carriage of a non-avalent pneumococcal conjugate vaccine. Journal of Infectious Diseases 180, 1171-6.
25. Obaro, S. K., Adegbola, R. A., Banya, W. A. et al. (1996). Carriage of pneumococci after pneumococcal vaccination. Lancet 348, 271-2.
26. Whitney, C. G., Farley, M. M., Hadler, J. et al. (2003). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New England Journal of Medicine 348, 1737-46.